354 related articles for article (PubMed ID: 6555189)
21. In-vitro activities of 16 non-beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Verhaegen J; Verbist L
J Antimicrob Chemother; 1999 Apr; 43(4):563-7. PubMed ID: 10350388
[TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
23. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Apr; 38(4):898-900. PubMed ID: 8031069
[TBL] [Abstract][Full Text] [Related]
24. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem.
Hupková H; Trupl J
Folia Microbiol (Praha); 1998; 43(1):68-70. PubMed ID: 9569631
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of relatively penicillin-resistant Streptococcus pneumoniae to newer cephalosporin antibiotics.
Bosley GS; Elliott JA; Oxtoby MJ; Facklam RR
Diagn Microbiol Infect Dis; 1987 May; 7(1):21-7. PubMed ID: 3691031
[TBL] [Abstract][Full Text] [Related]
26. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Chau PY; Ling J; Ng WS
J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
McCracken GH; Sakata Y
Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
[TBL] [Abstract][Full Text] [Related]
28. Penicillin-intermediate pneumococci in a children's hospital.
Willett LD; Dillon HC; Gray BM
Am J Dis Child; 1985 Oct; 139(10):1054-7. PubMed ID: 4036893
[TBL] [Abstract][Full Text] [Related]
29. Increasing incidence of penicillin- and cefotaxime-resistant
Verghese VP; Veeraraghavan B; Jayaraman R; Varghese R; Neeravi A; Jayaraman Y; Thomas K; Mehendale SM
Indian J Med Microbiol; 2017; 35(2):228-236. PubMed ID: 28681811
[TBL] [Abstract][Full Text] [Related]
30. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
[TBL] [Abstract][Full Text] [Related]
31. Austrian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae 1994-96.
Georgopoulos A; Buxbaum A; Straschil U; Graninger W
Scand J Infect Dis; 1998; 30(4):345-9. PubMed ID: 9817512
[TBL] [Abstract][Full Text] [Related]
32. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
Pikis A; Donkersloot JA; Akram S; Keith JM; Campos JM; Rodriguez WJ
J Antimicrob Chemother; 1997 Jul; 40(1):105-8. PubMed ID: 9249211
[TBL] [Abstract][Full Text] [Related]
33. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.
John CC
Clin Infect Dis; 1994 Feb; 18(2):188-93. PubMed ID: 8161625
[TBL] [Abstract][Full Text] [Related]
34. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Prince AS; Neu HC
Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
[TBL] [Abstract][Full Text] [Related]
35. Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Cottagnoud M; Acosta F; Täuber MG
Antimicrob Agents Chemother; 2003 Jun; 47(6):1943-7. PubMed ID: 12760871
[TBL] [Abstract][Full Text] [Related]
36. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.
Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 May; 41(5):1033-6. PubMed ID: 9145864
[TBL] [Abstract][Full Text] [Related]
37. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.
Fitoussi F; Doit C; Benali K; Bonacorsi S; Geslin P; Bingen E
Antimicrob Agents Chemother; 1998 Apr; 42(4):942-4. PubMed ID: 9559815
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics.
Goldstein EJ; Gombert ME; Agyare EO
Antimicrob Agents Chemother; 1980 Nov; 18(5):832-3. PubMed ID: 7004350
[TBL] [Abstract][Full Text] [Related]
39. Penicillin-resistant pneumococcal meningitis in Israel.
Steinberg T; Rachmel A; Samra Z; Ashkenazi S
Isr J Med Sci; 1997 Nov; 33(11):757-9. PubMed ID: 9434816
[TBL] [Abstract][Full Text] [Related]
40. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
Stratton CW; Aldridge KE; Gelfand MS
Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
